Differential expression of GHRH receptor and its splice variant 1 in human normal and malignant mucosa of the oesophagus and colon

International Journal of Oncology

Volumn 33, Issue 1, 2008, Pages 137-143

  Hohla, Florian ^a   Moder, Angelika ^a   Mayrhauser, Ursula ^a   Hauser Kronberger, Cornelia ^a   Schally, Andrew V ^b,c   Varga, Jozsef L ^b,c   Zarandi, Marta ^b,c   Buchholz, Stefan ^d   Huber, Rudolf ^a   Aigner, Elmar ^a   Ritter, Markus ^a   Datz, Christian ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Adenoma carcinoma sequence; Barrett's oesophagus; Colon cancer

Indexed keywords

GROWTH HORMONE RELEASING FACTOR RECEPTOR; HORMONE RECEPTOR; MESSENGER RNA; SPLICE VARIANT 1 RECEPTOR; UNCLASSIFIED DRUG; CYCLIN D1; GROWTH HORMONE RELEASING FACTOR; NEUROPEPTIDE RECEPTOR; SOMATOTROPIN RELEASING HORMONE RECEPTOR;

ARTICLE; BARRETT ESOPHAGUS; COLON ADENOMA; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER TUMOR; NEUROSECRETORY CELL; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL; STOMACH TUMOR; CHEMISTRY; COLON; COLON TUMOR; DRUG ANTAGONISM; ESOPHAGUS; ESOPHAGUS TUMOR; GENETICS; INTESTINE MUCOSA; PHYSIOLOGY; RNA SPLICING;

COLON; COLONIC NEOPLASMS; CYCLIN D1; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GROWTH HORMONE-RELEASING HORMONE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; RECEPTORS, NEUROPEPTIDE; RECEPTORS, PITUITARY HORMONE-REGULATING HORMONE; RNA SPLICING; RNA, MESSENGER;

EID: 51049095166     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.33.1.137     Document Type: Article

References (24)

1. Schally AV, Comaru-Schally AM, Nagy A, et al: Hypothalamic hormones and cancer. Front Neuroendocrinol 22: 248-291, 2001.
2. Busto R, Schally AV, Varga JL, et al: The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas. Proc Natl Acad Sci USA 99: 11866-11871, 2002.
3. Halmos G, Schally AV, Czompoly T, Krupa M, Varga JL and Rekasi Z: Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer. J Clin Endocrinol Metab 87: 4707-4714, 2002.
4. Halmos G, Schally AV, Varga JL, Plonowski A, Rekasi Z and Czompoly T: Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone. Proc Natl Acad Sci USA 97: 10555-10560, 2000.
5. Havt A, Schally AV, Halmos G, et al: The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues. Proc Natl Acad Sci USA 102: 17424-17429, 2005.
6. Hohla F, Schally AV, Szepeshazi K, et al: Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel. Proc Natl Acad Sci USA 103: 14513-14518, 2006.
7. Barabutis N, Tsellou E, Schally AV, Kouloheri S, Kalofoutis A and Kiaris H: Stimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor. Proc Natl Acad Sci USA 104: 5575-5579, 2007.
8. Kiaris H, Chatzistamou I, Schally AV, et al: Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor. Proc Natl Acad Sci USA 100: 9512-9517, 2003.
9. Kiaris H, Schally AV, Busto R, Halmos G, Artavanis-Tsakonas S and Varga JL: Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs. Proc Natl Acad Sci USA 99: 196-200, 2002.
10. Toiler GL, Horvath JE, Schally AV, et al: Development of a polyclonal antiserum for the detection of the isoforms of the receptors for human growth hormone-releasing hormone on tumours. Proc Natl Acad Sci USA 101: 15160-15165, 2004.
11. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
12. Kiaris H, Koutsilieris M, Kalofoutis A and Schally AV: Growth hormone-releasing hormone and extra-pituitary tumourigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists. Expert Opin Investig Drugs 12: 1385-1394, 2003.
13. Kiaris H, Schally AV and Kalofoutis A: Extrapituitary effects of the growth hormone-releasing hormone. Vitam Horm 70: 1-24, 2005.
14. Schally AV and Varga JL: Antagonists of growth hormone-releasing hormone in oncology. Comb Chem High Throughput Screen 9: 163-170, 2006.
15. Pombo CM, Zalvide J, Gaylinn BD and Dieguez C: Growth hormone-releasing hormone stimulates mitogen-activated protein kinase. Endocrinology 141: 2113-2119, 2000.
16. Arber N, Lightdale C, Rotterdam H, et al: Increased expression of the cyclin D1 gene in Barrett's oesophagus. Cancer Epidemiol Biomarkers Prev 5: 457-459, 1996.
17. Bani-Hani K, Martin IG, Hardie LJ, et al: Prospective study of cyclin D1 overexpression in Barrett's oesophagus: association with increased risk of adenocarcinoma. J Natl Cancer Inst 92: 1316-1321, 2000.
18. Siriwardana G, Bradford A, Coy D and Zeitler P: Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase. Mol Endocrinol 20: 2010-2019, 2006.
19. Morson B: President's address. The polyp-cancer sequence in the large bowel. Proc R Soc Med 67: 451-457, 1974.
20. Chung DC: The genetic basis of colorectal cancer: insights 854-865, 2000.
21. Kanashiro CA, Schally AV, Groot K, Armatis P, Bernardino AL and Varga JL: Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin. Proc Natl Acad Sci USA 100: 15836-15841, 2003.
22. Szepeshazi K, Schally AV, Groot K, et al: Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers. Br J Cancer 82: 1724-1731, 2000.
23. Carroll RE, Matkowskyj KA, Chakrabarti S, McDonald TJ and Benya RV: Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humans. Am J Physiol 276: G655-G665, 1999.
24. McElvaine AT and Mayo KE: A dominant-negative human growth hormone-releasing hormone (GHRH) receptor splice variant inhibits GHRH binding. Endocrinology 147: 1884-1894, 2006.